News

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.
Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.
The programme comprises two Phase III trials, ONWARD1 and ONWARD2, and an optional long-term extension trial, ONWARD3.
About 1 in 3 people with psoriasis who achieved clear skin with biologic drugs still had underlying inflammation that may ...
Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...
Healio: How problematic are treatment delays in head and neck cancer? Graboyes: Unlike some cancers — breast, lung, colon or prostate, for example — there is no screening test for head and ...
The patches can also be more widespread on black skin making it harder to distinguish psoriasis from other conditions. However, a cream medication that eases skin inflammation might offer a safer ...
How does one live with psoriasis? From medication to nutrition (and beyond), Olivia Marks goes in search of clear answers.
Discoloration isn’t permanent, and a healthcare provider can offer treatment to speed up your body ... forehead, back of the neck, and around the ears. Scalp psoriasis is often hard to treat in ...
“In addition to the skin, psoriasis can also affect joints resulting in psoriatic arthritis.” Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and ...
Many others at his level would have done just that. Instead, the Colts Neck senior proposed an audacious triple to longtime head coach Jim Schlentz – the 800, 1600 and 3200 at the NJSIAA sectionals.